Anandamide reduces excitability by preferentially targeting somatic VGSCs via CB1
Luke J Steiger, Timur Sh. Tsintsadze, Glynis B. Mattheisen, Stephen M. Smith
The paper identifies a pathway by which anandamide inhibits neuronal excitability through somatic VGSCs via CB1 activation in neocortical neurons.